Ignacio G. N.
- Country
- Spain
- Department
- Allergy
Research Overview
- Subcutaneous Dermatophagoides/Lepidoglyphus immunotherapy for moderate-to-severe allergic rhinitis/rhinoconjunctivitis with mild-to-moderate asthma: randomized placebo-controlled trial
- A multicenter, double-blind, placebo-controlled, clinical trial to evaluate the efficacy and safety of two concentrations of a mixture of depigmented polymerized allergenic extracts of D. pteronyssinus and D. farinae, in patients suffering from allergic rhinoconjunctivitis with or without controlled asthma
Data & Insights
Has run more than one trial at 2 of 37 partner sites.
Specializations
Allergology & Respiratory Medicine
The investigator specializes in the therapeutic management of allergic respiratory conditions, with particular focus on innovative treatment approaches for patients with moderate to severe allergic responses.
- Dust Mite Allergy Treatment
- Grass and Olive Tree Allergen Therapy
- Polymerized Allergen Extract Applications
Their research encompasses the development of immunotherapy solutions for various environmental allergens.
Respiratory Disease Management
Primary expertise centers on the treatment of rhinitis and rhinoconjunctivitis, ranging from intermittent to persistent presentations, with additional focus on asthma management.
- Allergic Rhinitis Treatment
- Rhinoconjunctivitis Care
- Controlled Asthma Management
The investigator employs comprehensive approaches in treating combined respiratory conditions.
Therapeutic Innovation
Focuses on advancing subcutaneous immunotherapy treatments and evaluating novel therapeutic approaches for allergic conditions.
- Immunotherapy Development
- Allergen-Specific Treatments
- Clinical Efficacy Assessment
Their work contributes to the advancement of targeted allergy treatments through controlled therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.